Long-term persistence of NMDAR antibodies after encephalitis with de novo occurrence of demyelinating disorder.
Clinical course
Encephalitis
NMDAR antibodies
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
01
06
2020
accepted:
15
09
2020
pubmed:
30
9
2020
medline:
15
5
2021
entrez:
29
9
2020
Statut:
ppublish
Résumé
The issue of persistence of NMDAR antibodies after encephalitis is not fully elucidated and their relationship with demyelinating disorders has been suggested. A female patient showed at the age of 18 an acute neurological disorder (with psychiatric symptoms, focal seizures, orofacial dyskinesias and hypoventilation requiring ventilatory support) clinically mimicking anti-NMDAR encephalitis. At that time specific laboratory tests were not available, CSF revealed oligoclonal bands and MRI was negative. The patient had full recovery after first line immunotherapy (i.v. steroids and immunoglobulins). Fifteen years later, at the age of 33, she was hospitalized with subacute right hemiparesis and MRI disclosed multiple T2 hyperintensities in the white matter, one of them in the left midbrain showing contrast enhancement. Serum and CSF NMDAR antibodies were positive while MOG and AQP4 antibodies were negative. Intravenous methylprednisolone led to complete recovery. This case report provides evidence of a long-term persistence of NMDAR antibodies even 15 years after the encephalitis and raises the suspicion of a possible causal relationship between NMDAR antibodies and demyelinating disorders in the form of multiple sclerosis.
Identifiants
pubmed: 32989588
doi: 10.1007/s10072-020-04729-3
pii: 10.1007/s10072-020-04729-3
doi:
Substances chimiques
Autoantibodies
0
Receptors, N-Methyl-D-Aspartate
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
301-303Références
Dalmau J, Armanguè T, Planagumà J et al (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 18:1045–1057
doi: 10.1016/S1474-4422(19)30244-3
Titulaer MJ, Hoftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis [J]. Ann Neurol 75(3):411–428
doi: 10.1002/ana.24117
Baheerathan A, Brownlee WJ, Chard DT, Shields K, Gregory R, Trip SA (2017) Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosis. Mult Scler Relat Disord. 12:20–22. https://doi.org/10.1016/j.msard.2016.12.009
doi: 10.1016/j.msard.2016.12.009
pubmed: 28283100
Lekoubou A, Viaccoz A, Didelot A, Anastasi A, Marignier R, Ducray F, Rogemond V, Honnorat J (2012) Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features. Eur J Neurol 19(2):e16–e17
doi: 10.1111/j.1468-1331.2011.03617.x
Ran Y, Wang L, Zhang F, Ao R, Dong Z, Yu S (2017) Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: a case report and literature review. Clin Neurol Neurosurg 155:75–82. https://doi.org/10.1016/j.clineuro.2017.02.016
doi: 10.1016/j.clineuro.2017.02.016
pubmed: 28282627
Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70:504–511
doi: 10.1212/01.wnl.0000278388.90370.c3
Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, Mccracken L, Leypoldt F et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13:167–177
doi: 10.1016/S1474-4422(13)70282-5
Hansen HC, Klingbeil C, Dalmau J, Li W, Weissbrich B, Wandinger KP (2013) Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol 70:117–119
doi: 10.1001/jamaneurol.2013.585
Waschbisch A, Kallmunzer B, Schwab S et al (2014) Demyelinating disease and anti-NMDAR IgG antibodies: a case report. Ann Neurol 75:411–428
doi: 10.1002/ana.24117
Uzawa A, Mori M, Takahashi Y, Ogawa Y, Uchiyama T, Kuwabara S (2012) Anti-N-methyl D-aspartate-type glutamate receptor antibody-positive limbic encephalitis in a patient with multiple sclerosis. Clin Neurol Neurosurg 114:402–404
doi: 10.1016/j.clineuro.2011.10.047